Condition
Ductal Adenocarcinoma of Pancreas clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Ductal Adenocarcinoma of Pancreas clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), China (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
GKL-006 injections with nab-paclitaxel and gemcitabine for advanced pancreatic cancer
This study tests GKL-006 given with standard chemotherapy to see if it helps patients with unresectable or metastatic pancreatic ductal adenocarcinoma.
-
PancreasPlus app for monitoring recovery, symptoms, and education after pancreatic cancer treatment
This project will test whether the PancreasPlus app helps adults with pancreatic cancer and their caregivers monitor symptoms, get timely information, and communicate with their healthcare team.
Related topics
Quick answers
How many Ductal Adenocarcinoma of Pancreas clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.